Surfactant protein C esters
AssigneeAltana Pharma AG
InventorsWolf-Rudiger Ulrich, Ernst Sturm
Life of this patent
Estimating the term…
Abstract
Novel surfactant protein C esters suitable for preparing pharmaceutical compositions for the treatment of infant respiratory distress syndrome and adult respiratory distress syndrome are described.
Claims7
-10. (canceled)
A method of treating pneumonia, bronchitis, meconim aspiration syndrome, Chronic Obstructive Pulmonary Disease (COPD), asthma, cystic fibrosis, Infant Respiratory Distress Syndrome (IRDS) and/or Adult Respiratory Distress Syndrome (ARDS) in a patient, comprising administering to a patient in need thereof a therapeutically effective amount of surfactant protein C (SP-C) in which the amino acid at the carboxy terminus of the surfactant protein is esterified with an alcohol having 1-4 carbon atoms, or a pharmacologically acceptable salt thereof.
Dependencies are inferred from the claim text.